semaglutide canada patent Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely? On March 20, 2026, the protecting Novo Nordisk's expired in India. Within 24 hours, the market transformed. Leading pharmaceutical giants Aspen Pharmacare wins Canada approval

For instance, a large network meta-analysis showed that SGLT-2 inhibitors reduced hospitalization for HF and renal composite outcome more than GLP-1RA [15], and that in patients with cardiovascular disease, SGLT-2 inhibitors show significant reduction in both heart failure (HF) hospitalizations and mortality for patients with HF and reduced ejection fraction [16]

SELF FUNDING Many firms particularly larger firms have self-funded health plans, which means that they pay for the health services of enrollees directly from their own funds rather than through the purchase of health insurance

Hesitation or slow insertion typically increases discomfort

How PlexusDx Supports a More Personalized Approach PlexusDx's precision-wellness model recognizes that antioxidant and detoxification capacity varies by individual genetics and current metabolic state

A peptide cycle guide compares reported active periods, breaks, study durations, and evidence limits for a peptide or blend